MarketCap
Facebook
X
TelegramMisonix, Inc. Revenue 2011-2026 | MSON
Company revenue is the total amount of money received from the sale of goods or services over a certain period of time. It is one of the key indicators of a company's financial condition and success.
Traditionally defined as follows:Revenue = Price * Quantity of productsRevenue is one of the components of a company’s income. In international practice, revenue is understood as the inflow or other increase in a company's assets or the settlement of its obligations that occurs as a result of the company’s core or main activity.[1]
This is an important indicator for assessing the financial condition and efficiency of a company. It makes it possible to determine how successfully a company sells its products or services on the market. In addition, revenue can be used to calculate other financial indicators such as profit, profitability, and market share.
Various factors can influence this indicator, including demand for goods or services, market competition, economic conditions, and the company's marketing efforts. Therefore, its analysis and monitoring are important tasks for the successful development of a business.
Annual Revenue Misonix, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 62.5 M | 38.8 M | 36.7 M | 27.3 M | 23.1 M | 22.2 M | 17.1 M | 14.8 M | 15.7 M | 14.4 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 62.5 M | 14.4 M | 27.3 M |
References
- Adhikari, B. (2010). Impact of Revenue Planning In Nepal Investment Bank Limited (Doctoral dissertation, Faculty of Management).
Revenue of other stocks in the Medical devices industry
| Issuer | Revenue | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Alphatec Holdings
ATEC
|
764 M | $ 11.29 | 3.58 % | $ 1.69 B |  USA |
 |
AxoGen
AXGN
|
225 M | $ 33.05 | 3.41 % | $ 1.52 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
172 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
7.16 M | - | -26.83 % | $ 2.62 M | USA |
 |
Align Technology
ALGN
|
4 B | $ 179.93 | 3.92 % | $ 13.5 B | USA |
 |
AdaptHealth Corp.
AHCO
|
3.24 B | $ 12.43 | 2.14 % | $ 1.68 B | USA |
 |
Allied Healthcare Products
AHPI
|
6.02 M | - | 3.58 % | $ 2.21 M | USA |
 |
Cytosorbents Corporation
CTSO
|
37.1 M | $ 0.6 | -2.07 % | $ 37.3 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
274 M | - | - | $ 3.31 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
1.59 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
2.57 B | $ 287.63 | 3.05 % | $ 8.12 B | USA |
 |
EDAP TMS S.A.
EDAP
|
44.1 M | $ 3.38 | 2.42 % | $ 127 M |  France |
 |
BioSig Technologies
BSGM
|
40 K | - | 37.08 % | $ 85.7 M | USA |
 |
Conformis
CFMS
|
62 M | - | - | $ 16.4 M | USA |
 |
Bruker Corporation
BRKR
|
3.37 B | $ 38.99 | 3.74 % | $ 5.81 K | USA |
 |
Boston Scientific Corporation
BSX
|
20.1 B | $ 63.02 | 2.04 % | $ 93.3 B | USA |
 |
Apollo Endosurgery
APEN
|
76.9 M | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
236 M | - | 0.15 % | $ 844 M | USA |
 |
ClearPoint Neuro
CLPT
|
37 M | $ 9.88 | 13.77 % | $ 280 M | USA |
 |
Helius Medical Technologies
HSDT
|
644 K | $ 1.97 | 4.23 % | $ 1.2 M | USA |
 |
Dynatronics Corporation
DYNT
|
27.4 M | - | 14.99 % | $ 929 K | USA |
 |
IRIDEX Corporation
IRIX
|
52.7 M | $ 1.02 | 2.01 % | $ 17.3 M | USA |
 |
Electromed
ELMD
|
64 M | $ 24.7 | 2.4 % | $ 209 M | USA |
 |
CryoLife, Inc.
CRY
|
253 M | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
7.65 M | - | -20.74 % | $ 369 K | USA |
 |
Second Sight Medical Products
EYES
|
1 K | - | -0.97 % | $ 54.4 M | USA |
 |
Inogen
INGN
|
349 M | $ 6.44 | 1.74 % | $ 171 M | USA |
 |
Aziyo Biologics
AZYO
|
12.3 M | - | 1.37 % | $ 20.5 M | USA |
 |
LivaNova PLC
LIVN
|
1.39 B | $ 64.47 | 2.69 % | $ 3.52 B |  Britain |
 |
LENSAR
LNSR
|
58.4 M | $ 5.9 | 3.55 % | $ 70.6 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
4.25 K | - | -1.98 % | $ 98.3 M | USA |
 |
GBS
GBS
|
3.05 M | - | -0.57 % | $ 7.12 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
41 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Neovasc
NVCN
|
2.55 M | - | - | $ 111 M |  Canada |
 |
OrthoPediatrics Corp.
KIDS
|
236 M | $ 16.92 | 5.95 % | $ 397 M | USA |
 |
Globus Medical
GMED
|
2.94 B | $ 92.74 | 2.62 % | $ 12.5 B | USA |
 |
Butterfly Network
BFLY
|
82.1 M | $ 4.28 | 4.27 % | $ 906 M | USA |
 |
Intersect ENT, Inc.
XENT
|
80.6 M | - | - | $ 955 M | USA |
 |
BIOLASE
BIOL
|
49.2 M | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
85.2 M | $ 10.45 | 4.03 % | $ 374 M | USA |
 |
Myomo
MYO
|
40.9 M | $ 0.72 | 4.35 % | $ 30.1 M | USA |
 |
Inspire Medical Systems
INSP
|
912 M | $ 54.65 | 1.2 % | $ 1.61 B | USA |
 |
CONMED Corporation
CNMD
|
1.37 B | $ 38.52 | 4.83 % | $ 1.2 B | USA |
 |
NanoVibronix
NAOV
|
2.56 M | - | - | $ 1.08 M | USA |
 |
Integer Holdings Corporation
ITGR
|
1.85 B | $ 87.51 | 2.78 % | $ 3.04 B | USA |
 |
FONAR Corporation
FONR
|
97.6 M | $ 18.67 | -0.05 % | $ 122 M | USA |